Schonfeld Strategic Advisors’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,204
| Closed | -$475K | – | 2051 |
|
|
2025
Q1 | $475K | Buy |
+50,204
| New | +$475K | ﹤0.01% | 1485 |
|
|
2024
Q3 | – | Sell |
-59,470
| Closed | -$1.14M | – | 1978 |
|
|
2024
Q2 | $1.14M | Buy |
59,470
+51,870
| +683% | +$992K | 0.01% | 1026 |
|
|
2024
Q1 | $249K | Buy |
+7,600
| New | +$249K | ﹤0.01% | 1536 |
|
|
2023
Q4 | – | Sell |
-25,300
| Closed | -$689K | – | 1847 |
|
|
2023
Q3 | $689K | Sell |
25,300
-5,300
| -17% | -$144K | 0.01% | 1007 |
|
|
2023
Q2 | $927K | Sell |
30,600
-70,900
| -70% | -$2.15M | 0.01% | 994 |
|
|
2023
Q1 | $3.29M | Buy |
+101,500
| New | +$3.29M | 0.03% | 552 |
|
|
2022
Q4 | – | Sell |
-185,000
| Closed | -$6.65M | – | 2612 |
|
|
2022
Q3 | $6.65M | Buy |
185,000
+97,500
| +111% | +$3.5M | 0.06% | 438 |
|
|
2022
Q2 | $2.69M | Buy |
87,500
+25,600
| +41% | +$786K | 0.03% | 610 |
|
|
2022
Q1 | $2M | Buy |
61,900
+30,345
| +96% | +$980K | 0.02% | 690 |
|
|
2021
Q4 | $873K | Buy |
31,555
+20,855
| +195% | +$577K | 0.01% | 939 |
|
|
2021
Q3 | $331K | Sell |
10,700
-7,856
| -42% | -$243K | ﹤0.01% | 1400 |
|
|
2021
Q2 | $392K | Buy |
+18,556
| New | +$392K | ﹤0.01% | 1274 |
|
|
2020
Q2 | – | Sell |
-17,900
| Closed | -$97K | – | 1289 |
|
|
2020
Q1 | $97K | Buy |
+17,900
| New | +$97K | 0.01% | 1006 |
|
|
2019
Q1 | – | Sell |
-70,000
| Closed | -$1.4M | – | 1066 |
|
|
2018
Q4 | $1.4M | Buy |
70,000
+20,000
| +40% | +$399K | 0.05% | 391 |
|
|
2018
Q3 | $1.42M | Sell |
50,000
-10,000
| -17% | -$284K | 0.06% | 358 |
|
|
2018
Q2 | $1.26M | Buy |
+60,000
| New | +$1.26M | 0.07% | 354 |
|
|
2017
Q4 | – | Sell |
-50,000
| Closed | -$890K | – | 749 |
|
|
2017
Q3 | $890K | Buy |
+50,000
| New | +$890K | 0.08% | 285 |
|